Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(23)00427-3/fulltext?dgcid=hubspot_email_covidalerts&utm_campaign=lancetcovid22&utm_medium=email&_hsmi=283901121&_hsenc=p2ANqtz--3B5SesbERy6JZkQIAOAX9uYkNeUmj6KopEoQ48hVkYgEarWyzZLJvEnpQ0-uLTxgPFOmTMurCes7rJurKLCxw1Ru9ow&utm_content=283899141&utm_source=hs_email